חזרה לתוצאות החיפוש

A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE3

מצבים רפואיים

Renal Cell Carcinoma

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • University Of UA Cancer Center(UACC)/DH-SJHMC, Phoenix, Arizona, United States

  • University of California Davis Comprehensive Cancer Center, Sacramento, California, United States

  • UCSF Helen Diller Family Comphrensive Cancer Center - Hemato, San Francisco, California, United States

  • Norton Cancer Institute, Norton Healthcare Pavilion, Louisville, Kentucky, United States

  • Ochsner Clinic Foundation, New Orleans, Louisiana, United States

  • GU Research Network/Urology Cancer Center, Omaha, Nebraska, United States

  • Nebraska Cancer Specialists, Omaha, Nebraska, United States

  • Northwell Health/Monter Cancer Center, Lake Success, New York, United States

  • Mainstreet Physicans Care, Rochester, New York, United States

  • Precision Cancer Research/Dayton Physicians Network - Treatment, Kettering, Ohio, United States

  • Oregon Health and Science University, Portland, Oregon, United States

  • St. Luke's Hospital, Easton, Pennsylvania, United States

  • HOPE Cancer Center of East Texas, Tyler, Texas, United States

  • Medical Oncology Associates, PS (dba Summit Cancer Centers), Spokane, Washington, United States

  • Beijing Cancer Hospital, Beijing, China

    Contact: Study coordinator (Bixia Tang, MD, PhD) · bixiatang_med@126.com · 13810211044

  • Zhongshan Hospital Affiliated to Fudan University, Shanghai, China

    Contact: Study coordinator (Xiaoyi Hu, MD, PhD) · hu.xiaoyi@zs-hospital.sh.cn · 13917166233

  • Fondazione del Piemonte per l'Oncologia_Istituto di Candiolo, IRCCS_ Oncologia Medica, Candiolo, Italy

  • A.O. Cannizzaro_UOS Oncologia Medica, Catania, Italy

  • IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) UO Oncologia Medica, Meldola (FC), Italy

  • Istituto Europeo di Oncologia_Unità Oncologia Medica Urogenitale e Cervico Facciale, Milan, Italy

  • Istituto Nazionale dei Tumori-Fondazione Pascale- SC Oncologia Medica, Naples, Italy

  • Azienda Ospedaliero-Universitaria Maggiore della Carità Novara_SC Oncologia Medica, Novara, Italy

  • Istituti Clinici Scientifici Maugeri Spa-SB_ UO Oncologia Medica, Pavia, Italy

  • Azienda Ospedaliero Universitaria Pisana_ UO Oncologia Medica Universitaria, Pisa, Italy

  • Fondazione Policlinico Universitario A. Gemelli, U.O.C. Oncologia Medica, Roma, Italy

  • Szpital Specjalistyczny w Brzozowie Podkarpacki Osrodek Onkologiczny, Brzozów, Poland

  • Szpitale Pomorskie Sp. z o.o. Oddział Onkologii i Radioterapii, Gdynia, Poland

  • Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie Sp. z o.o. Oddział Onkologii Klinicznej z Pododdziałem Dziennym, Krakow, Poland

  • Clinical Research Center Sp. z o.o., Medic-R Sp. K., Poznan, Poland

  • National Cancer Center - Center For Prostate Cancer, Goyang-si, South Korea

  • CHA Bundang Medical Center, CHA University, Seongnam-si, South Korea

  • Severance Hospital, Yonsei University Health System - Medical Oncology, Seoul, South Korea

  • Asan Medical Center - University of Ulsan College of Medicin, Seoul, South Korea

  • Samsung Medical Center - Hematology-Oncology, Seoul, South Korea

  • H.G.U. de Elche, Elche, Spain

  • Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain

  • Hospital Universitario 12 de Octubre, Madrid, Spain

  • H.U. Virgen de la Victoria, Málaga, Spain

מובילי המחקר

  • Pamela Munster, M.D.

    Study Chair

    University of California, San Francisco

  • Rahul Aggarwal, M.D.

    Study Chair

    University of California, San Francisco

צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)